adenoma: The congenital absence of the thyroid gland.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
82 |
4. Check minimum number of eventsNone |
82 |
5. Include endpointsNone |
82 |
6. Filter based on genotype QC (FinnGen only) |
82 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D35
- Name in latin
- Neoplasma benignum corporis pinealis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Pineal gland
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Pineal gland
- Benign neoplasm of other and unspecified endocrine glands
- Benign neoplasm of other and unspecified endocrine glands
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 487 | 326 | 160 |
| Only index persons | 454 | 312 | 142 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.00 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 32.24 | 32.69 | 31.22 |
| Only index persons | 31.98 | 31.98 | 31.98 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 82 | 61 | 21 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | 36.89 | 35.46 | 41.04 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 76
- Matched controls
- 757
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D35.4
ICD-10 Finland
Benign neoplasm: Pineal gland
+∞
101.4
73
*
G93.0
ICD-10 Finland
Cerebral cysts
113.6
9.7
10
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
7.2
8.1
20
36
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
50.4
7.9
9
*
R51.80
ICD-10 Finland
Headache
4.4
7.0
28
88
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016018) Differential panel - Cerebral spinal fluid
6
5
12.79
3.82
1.0
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
8
12
7.25
3.77
1.0
1.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
8
13
6.69
3.59
7.1
8.6
%
91.7
94.7
—
8
13
(3023410) Appearance of Cerebral spinal fluid
6
6
10.65
3.55
1.0
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
66
488
2.81
3.50
3.4
3.6
mm/h
7.7
8.7
0.41
59
452
(3035637) Corticotropin [Mass/volume] in Plasma
6
8
7.98
3.11
1.0
1.9
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
5
5
10.52
3.02
1.8
2.2
nmol/l
14.0
24.9
—
5
5
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
26
136
2.34
2.94
1.9
1.8
mg/l
0.6
0.7
0.03
20
102
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
15
4.99
2.66
1.4
1.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
7
15
4.99
2.66
7.7
7.4
%
0.9
0.8
—
7
15
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
7
15
4.99
2.66
7.9
7.4
%
2.1
1.2
—
7
15
(3032080) INR in Blood by Coagulation assay
31
185
2.09
2.50
3.5
5.4
inr
1.0
1.1
—
8
58
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
74
635
2.69
2.17
5.3
4.6
mu/l
1.6
1.7
0.42
65
595
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
10
5.24
2.10
1.0
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
65
525
2.15
2.09
4.7
4.1
pmol/l
14.6
14.4
0.26
57
486
(3013512) EKG study
23
136
1.96
1.84
3.1
2.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
29
188
1.84
1.76
3.7
2.6
ng/l
11.5
14.0
0.57
14
87
(3018405) Lactate [Moles/volume] in Arterial blood
5
13
4.02
1.74
11.0
2.8
mmol/l
1.4
1.6
—
5
13
(3003396) Base excess in Arterial blood by calculation
9
38
2.53
1.51
8.9
5.2
mmol/l
1.5
1.6
—
9
26
(3020891) Body temperature
5
17
3.06
1.38
10.8
2.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
72
636
2.08
1.35
11.8
8.4
ml/min/173m2
92.5
95.7
0.55
61
512
(3019060) Gas panel - Arterial blood
6
24
2.61
1.33
10.7
3.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
6
24
2.61
1.33
2.3
6.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
24
159
1.72
1.32
1.8
1.9
—
—
—
0
0
(4034850)
5
18
2.89
1.30
4.4
14.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
29
204
1.65
1.28
3.4
2.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
74
673
2.02
1.18
11.4
11.3
%
39.0
40.2
0.48
58
567
(3004119) Hemoglobin [Mass/volume] in Venous blood
5
20
2.59
1.17
1.8
5.1
g/l
134.0
133.0
—
5
20
(3045414) Leukocytes [Presence] in Urine
5
21
2.47
1.10
2.0
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
13
75
1.87
1.10
1.2
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
9
45
2.12
1.09
3.1
2.0
—
—
—
0
0
(3044889) 12 lead EKG panel
49
402
1.54
1.08
2.8
2.8
—
—
—
0
0
(3019225) pH of Specimen
9
47
2.03
1.06
2.2
5.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
12
69
1.87
1.03
1.7
2.3
umol/l
15.8
14.0
0.53
12
64
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
7
36
2.03
0.99
1.7
1.7
—
—
—
0
0
(3012544) pH of Venous blood
7
36
2.03
0.99
1.9
4.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
24
171
1.57
0.98
3.5
3.8
mmol/l
2.4
2.4
0.88
19
154
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
55
469
1.52
0.97
7.4
7.1
u/l
73.4
73.6
0.02
50
438
(4035726)
7
37
1.97
0.96
1.0
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
23
163
1.57
0.96
1.2
1.4
g/l
2.3
2.2
0.12
15
102
(3024354) Oxygen [Partial pressure] in Venous blood
6
29
2.15
0.91
1.8
2.9
kpa
4.0
4.5
—
6
29
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
27
202
1.50
0.88
1.4
1.6
pmol/l
109.6
95.9
0.44
12
111
(3023368) Bacteria identified in Blood by Culture
17
118
1.56
0.77
4.2
3.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
68
619
1.58
0.77
3.7
3.4
mmol/l
5.6
5.7
0.36
60
579
(3021601) Nitrite [Presence] in Urine by Test strip
40
331
1.41
0.76
6.1
4.3
estimate
0.0
0.0
—
9
75
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
25
2.06
0.74
1.2
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
33
266
1.40
0.72
1.8
1.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
94
0.50
0.72
1.8
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
7
42
1.73
0.70
2.6
2.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
14
196
0.66
0.68
1.4
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
29
231
1.40
0.67
4.2
2.8
e6/l
151.3
33.4
0.50
23
153
(3009261) Glucose [Presence] in Urine by Test strip
40
337
1.36
0.66
5.2
3.2
estimate
0.0
0.0
—
9
73
(3048689) Calprotectin [Mass/mass] in Stool
16
114
1.50
0.65
3.3
2.2
ug/g
134.6
79.3
0.36
11
87
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14
97
1.53
0.64
1.1
1.6
pmol/l
452.1
490.1
0.15
14
83
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
21
0.00
0.61
0.0
1.1
—
1.5
—
0
10
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
0
23
0.00
0.59
0.0
1.1
—
2.8
—
0
11
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
23
0.00
0.59
0.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
0
23
0.00
0.59
0.0
2.7
—
3.8
—
0
11
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
18
135
1.43
0.57
1.6
1.9
mg/l
2.2
2.8
0.98
18
116
(3021447) Carbon dioxide [Partial pressure] in Venous blood
6
37
1.67
0.57
2.0
4.1
kpa
5.8
5.7
—
6
37
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
9
60
1.56
0.57
3.8
2.7
u/l
29.4
25.5
—
9
48
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
9
63
1.48
0.54
7.1
5.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
26
211
1.34
0.53
1.9
2.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
46
1.57
0.50
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
26
213
1.32
0.49
2.3
2.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
112
1.42
0.49
1.5
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
16
123
1.37
0.45
1.8
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
5
31
1.65
0.44
1.6
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
44
392
1.26
0.43
6.9
9.9
e9/l
4.2
3.9
0.52
39
349
(40761536) Microorganisms panel - Urine sediment
8
59
1.39
0.42
9.3
3.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
22
264
0.77
0.42
1.6
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(4268621)
0
17
0.00
0.41
0.0
2.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
17
0.00
0.41
0.0
1.1
—
95.9
—
0
17
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
12
89
1.41
0.40
2.3
1.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
35
1.46
0.40
1.6
1.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
21
172
1.30
0.39
3.5
2.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
24
202
1.27
0.37
6.9
6.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
10
73
1.42
0.36
1.1
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
23
193
1.27
0.36
2.1
2.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
13
101
1.34
0.34
2.9
2.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
19
157
1.27
0.33
3.8
2.9
ph
7.4
7.4
—
5
29
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
22
186
1.25
0.32
1.9
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
52
1.38
0.32
2.3
1.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
18
149
1.27
0.31
5.1
3.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
55
1.30
0.31
1.6
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
21
178
1.24
0.30
7.0
3.4
estimate
0.0
0.0
—
9
72
(3016879) Cocaine [Presence] in Urine
8
64
1.28
0.28
1.5
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
21
180
1.22
0.27
4.4
2.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
9
71
1.30
0.27
3.6
2.5
umol/l
3.7
6.6
—
9
63
(40768797) Stomach Pathology biopsy report
9
74
1.24
0.26
1.1
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
39
1.30
0.23
1.6
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
40
1.27
0.23
1.2
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
1.5
—
0
6
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
25
223
1.17
0.21
1.2
1.8
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.0
—
40.4
—
0
12
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.0
—
0.0
—
0
12
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.0
—
10.8
—
0
12
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.0
—
0.0
—
0
12
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
13
0.00
0.21
0.0
1.2
—
0.0
—
0
13
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
0
14
0.00
0.20
0.0
2.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
14
0.00
0.20
0.0
1.1
—
2.5
—
0
14
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
50
1.22
0.20
2.8
1.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
36
333
1.14
0.19
5.3
3.1
estimate
0.0
0.0
—
9
76
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
36
333
1.14
0.19
3.7
4.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
57
1.25
0.19
1.9
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
58
1.23
0.19
1.6
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
15
129
1.20
0.18
1.1
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
21
187
1.17
0.18
1.0
1.3
u/ml
0.6
1.2
—
7
51
(3028300) Cannabinoids [Presence] in Urine
8
67
1.21
0.17
1.6
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
67
1.21
0.17
1.6
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
67
1.21
0.17
1.6
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
68
1.20
0.17
1.8
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
8
70
1.16
0.17
1.1
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
62
598
1.15
0.16
15.6
13.0
%
13.3
13.4
0.54
62
592
(3042936) Bacteria identified in Isolate by Culture
9
81
1.12
0.15
1.4
2.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
28
259
1.12
0.14
5.5
3.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
63
649
0.87
0.14
4.1
3.3
mmol/l
1.6
1.5
0.83
58
613
(3012516) Albumin [Mass/volume] in Urine
14
124
1.16
0.12
8.1
3.1
mg/l
110.4
65.0
—
9
74
(1761868) Lipid panel - Serum or Plasma
24
259
0.90
0.12
2.6
2.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
18
163
1.13
0.12
7.9
7.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
11
125
0.86
0.11
1.6
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
47
1.07
0.09
3.4
3.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
5
47
1.07
0.09
1.4
1.9
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
6
54
1.12
0.09
4.5
2.8
e9/l
4.2
3.8
—
6
48
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
23
215
1.10
0.09
2.4
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
5
61
0.81
0.08
1.6
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
60
0.82
0.08
1.6
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
7
65
1.08
0.08
1.4
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
7
68
1.03
0.08
1.4
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
7
68
1.03
0.08
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
7
68
1.03
0.08
1.4
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
8
74
1.09
0.08
1.0
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
8
75
1.07
0.08
1.5
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
67
657
1.11
0.07
4.2
3.6
mmol/l
2.9
2.8
0.17
61
621
(3050129) First trimester maternal screen panel - Serum or Plasma
7
80
0.86
0.07
1.3
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
29
304
0.93
0.07
13.9
7.5
e9/l
0.0
0.0
0.50
24
250
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
102
0.87
0.07
2.0
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
104
0.85
0.07
1.3
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
18
168
1.09
0.06
4.8
5.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
21
198
1.08
0.06
4.5
2.7
—
—
—
0
0
(3015736) pH of Urine
25
262
0.93
0.05
5.0
2.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
49
478
1.06
0.05
5.9
4.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
11
120
0.90
0.05
1.3
1.2
u/ml
2.2
6.0
—
5
55
(3020682) Albumin/Creatinine [Ratio] in Urine
14
130
1.09
0.05
9.5
3.7
mg/mmol
34.1
7.8
—
9
79
(46235355) HIV 1 and 2 tests - Meaningful Use set
28
273
1.04
0.01
1.5
2.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
61
607
1.02
0.00
4.2
3.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
45
455
0.98
0.00
6.9
3.8
—
38.0
—
0
8
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
65
655
0.96
0.00
4.1
3.3
mmol/l
4.9
4.7
1.12
60
619
(3005033) Fetal Nuchal fold Thickness US
6
60
1.00
0.00
1.5
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
56
0.89
0.00
1.0
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
61
0.98
0.00
1.2
1.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
68
0.87
0.00
1.5
1.5
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
102.8
—
0
5
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
5.4
—
0
5
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
3.5
—
91.2
—
0
6
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
106.9
—
0
5
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
0.3
—
0
5
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
3.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
62
0.97
0.00
1.7
1.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
56.0
—
0
5
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
3.2
—
118.4
—
0
5
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
0.4
—
0
7
(3035285) Chloride [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
3.6
—
106.1
—
0
8
(4062490)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
8
0.00
0.00
0.0
3.6
—
4.0
—
0
8
(3026389) Candida sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.4
—
5.3
—
0
5
(3032773) Endomysium IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
0.2
—
0
5
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
126.4
—
0
5
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
818.4
—
0
5
(3000093) Morphology [Interpretation] in Blood Narrative
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
8
0.00
0.00
0.0
1.0
—
13.3
—
0
8
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_PINEAL and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_PINEAL.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_PINEAL – Benign neoplasm: Pineal gland
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data